REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Nulab Pharmaceutical Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Nulab Pharmaceutical Indonesia Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Nulab Pharmaceutical Indonesia is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Dki Jakarta. The company was founded in 2008. Nulab Pharmaceutical Indonesia was established by a group of visionary founders with a mission to enhance healthcare solutions in Indonesia. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and health supplements. As a key player in the Indonesian pharmaceutical industry, Nulab Pharmaceutical Indonesia operates several branches across major cities in the country, ensuring a robust local geographical footprint. The company is committed to providing high-quality and affordable healthcare products to meet the diverse needs of the Indonesian population. Nulab Pharmaceutical Indonesia's product portfolio includes well-known brands that cater to various therapeutic areas such as cardiovascular health, respiratory care, and pain management. The company is also actively involved in research and development to introduce innovative healthcare solutions. While primarily focused on the domestic market, Nulab Pharmaceutical Indonesia has begun exploring export opportunities in neighboring Southeast Asian countries, aiming to expand its global geographical footprint. The company collaborates with several local and international partners to enhance its product offerings and distribution capabilities. It is a member of various pharmaceutical associations, which helps it stay updated with industry trends and regulatory changes. Nulab Pharmaceutical Indonesia is dedicated to improving public health and well-being, guided by its vision to be a leading pharmaceutical company in the region. The company strives to achieve this through continuous innovation, quality assurance, and customer satisfaction.

Headquarters
Komplek Green Ville Maisonette Blok FB No. 5-6
West Jakarta; Jakarta; Postal Code: 11510

Contact Details: Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.

Website: http://www.nulabpharmaceutical.com

Basic Information
Total Employees:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Registered Capital:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Financial Auditors:
Purchase the PT Nulab Pharmaceutical Indonesia report to view the information.
Incorporation Date:
October 17, 2008
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
President Commissioner
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Nulab Pharmaceutical Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
11.36%
Total operating revenue
11.36%
Total assets
14.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?